BSEBoard Meeting5d ago · 13 Oct 2026, 04:45 pm
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the un-audited financial results of the Company for the quarter and half-year ended September 30, 2026 And Payment Of Interim Dividend for FY 2026-27
Laurus Labs Ltd · 540222
✦ AI SummaryResults
Laurus Labs Ltd has scheduled a Board Meeting on October 29, 2026, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2026, and to consider the proposal for payment of Interim Dividend for FY 2026-27.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Laurus Labs Ltd - 540222 - Board Meeting Intimation for Consideration Of The Un-Audited Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2026 And Payment Of Interim Dividend For FY 2026-27
Attachments (1)
📄pdf
Download →
1447da2d-258f-42ae-bd27-7ae9d2eb6ba6.pdf
View document text
October 13, 2026
To To
The Corporate Relations Department The Listing Department
BSE Limited National Stock Exchange of India Ltd.,
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex, Bandra (E),
Mumbai – 400 001 Mumbai – 400 051
Code: 540222 Code: LAURUSLABS
Dear Sir / Madam,
Sub: Board Meeting Intimation
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on
Thursday, October 29, 2026, inter-alia:
i. to consider and approve the un-audited financial results of the Company for the quarter and half-
year ended September 30, 2026.
ii. to consider the proposal for payment of Interim Dividend for FY 2026-27 and fixation of record
date for determining the eligibility of shareholders, if approved.
Further, the Company’s trading window for dealing in securities by the Directors and Designated
Persons has been closed from Thursday, October 01, 2026 which was already intimated on September
25, 2026 and shall continue to remain closed till Saturday, October 31, 2026 (both days inclusive).
This is for your information and records.
Thanking you,
Yours faithfully,
For Laurus Labs Limited
G. Venkateswar Reddy
Company Secretary & Compliance Officer